ε-Viniferin Rejuvenates Senescence via RGS16 Regulation: In Vitro Evidence

Area of Science:

• Biochemistry
• Cell Biology
• Aging Research

Background:

• Mitochondrial dysfunction and reactive oxygen species (ROS) are key drivers of cellular senescence and aging.
• Current anti-aging strategies targeting ROS are limited by a lack of effective components or treatments.

Purpose of the Study:

• To identify natural compounds that reduce mitochondrial ROS production.
• To investigate the anti-aging effects and underlying mechanisms of ε-viniferin.

Main Methods:

• Screening of plant-derived secondary metabolites for ROS-reducing properties.
• Assessing ε-viniferin's impact on mitochondrial function, ROS levels, and senescent cell elimination.
• Utilizing RNA sequencing to identify key molecular players in ε-viniferin's action.

Main Results:

• ε-viniferin was identified as a potent reducer of mitochondrial ROS by enhancing electron transport.
• ε-viniferin demonstrated senolytic activity, selectively clearing senescent fibroblasts and restoring cellular function.
• Upregulation of Regulator of G protein signaling 16 (RGS16) mimicked ε-viniferin's beneficial effects.

Conclusions:

• ε-viniferin rejuvenates senescence through a novel mechanism involving mitochondrial ROS reduction.
• RGS16 is identified as a crucial mediator of ε-viniferin's anti-aging effects.
• This discovery provides a foundation for developing novel therapeutics targeting mitochondrial ROS for aging.